Published guidance, NICE advice and quality standards | Guidance

Showing 861 to 870 of 1529

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis	ES29	21 July 2020	21 July 2020
Specialist neonatal respiratory care for babies born preterm	QS193	15 July 2020	15 July 2020
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic	MIB219	10 July 2020	10 July 2020
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer	TA638	1 July 2020	1 July 2020
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer	TA639	1 July 2020	1 July 2020
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal)	TA634	30 June 2020	30 June 2020
Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal)	TA635	30 June 2020	30 June 2020
Eculizumab for treating refractory myasthenia gravis (terminated appraisal)	TA636	30 June 2020	30 June 2020
Ranibizumab for treating diabetic retinopathy (terminated appraisal)	TA637	30 June 2020	30 June 2020
Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure	TA626	24 June 2020	24 June 2020